Clinical Trial Update: Quality of Life Study for Sickle Cell Patients Treated With Jobelyn (Sorghum Bicolor Extract) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 1/Phase 2 quality-of-life study evaluating Jobelyn (Sorghum bicolor extract) for sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Jobelyn

Snippet

Sponsor: Lagos State University | Conditions: Other Sickle-cell Disorders With Crisis, Unspecified | Phase 1, Phase 2 | Status: UNKNOWN